Stay updated on Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial
Sign up to get notified when there's something new on the Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial page.

Latest updates to the Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial page
- Check3 days agoChange DetectedNotice about a lapse in government funding is displayed, and the site revision has been updated to v3.4.1 (replacing v3.4.0). These changes are administrative and do not alter the study details or how users interact with the page.SummaryDifference0.4%

- Check10 days agoChange DetectedAdded a glossary toggle and updated metadata captions to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed the previous captions 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedMinor software revision updates detected: Revision: v3.3.4 added and Revision: v3.3.3 removed; no trial details, eligibility criteria, or study results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedA consolidated Locations section with state site listings (Alabama, Georgia, Illinois, Kansas, New York, Tennessee, Wisconsin) was added and the per-state location subsections were removed. The HHS Vulnerability Disclosure link was removed.SummaryDifference0.8%

- Check68 days agoChange DetectedThe page now shows Revision: v3.3.2 (replacing v3.3.1). This is a versioning detail and does not affect the study details or functionality.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed.SummaryDifference0.0%

Stay in the know with updates to Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial page.